NICE Ltd. (NICE) Income Statement
NICE 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsNICE revenue and net income
Where NICE's revenue goes
2025Each bar shows an amount and its share of revenue. NICE kept 20.8% of revenue as net income.
NICE profit margins
NICE growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +7.7% | +10.5% | +12.3% | +12.3% |
| Gross profit | +7.1% | +9.3% | +12.5% | +12.1% |
| Operating income | +18.3% | +24.4% | +21.7% | +14.5% |
| Net income | +38.3% | +32.0% | +25.5% | +9.0% |
| EPS (diluted) | +5.4% | +15.4% | +15.4% | +13.7% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
NICE quarterly EPS vs estimates
NICE beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 12, 2026 (estimate $2.11).
NICE income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.95B | $2.74B | $2.38B | $2.18B | $1.92B | $1.65B | $1.57B | $1.44B | $1.33B | $1.02B |
| Cost of revenue | $989.3M | $909.5M | $768.2M | $683.7M | $624.5M | $562.0M | $531.8M | $496.8M | $468.7M | $337.7M |
| Gross profit | $1.96B | $1.83B | $1.61B | $1.50B | $1.30B | $1.09B | $1.04B | $947.7M | $863.5M | $677.8M |
| Research & development | $360.4M | $360.6M | $322.7M | $306.1M | $271.2M | $218.2M | $193.7M | $183.8M | $181.1M | $141.5M |
| Sales, general & admin | $949.9M | $916.4M | $851.4M | $856.4M | $761.6M | $587.2M | $567.3M | $524.0M | $490.4M | $384.9M |
| Total operating expenses | $1.31B | $1.28B | $1.17B | $1.16B | $1.03B | $844.0M | $803.4M | $750.1M | $713.4M | $543.6M |
| Operating income | $645.8M | $546.0M | $435.2M | $335.2M | $263.9M | $242.0M | $238.7M | $197.6M | $150.1M | $134.2M |
| Interest income | $54.5M | $65.0M | $42.5M | $18.4M | $14.0M | $19.1M | $20.5M | $11.3M | $3.7M | $6.6M |
| Interest expense | $0 | $5.3M | $8.2M | $9.7M | $33.3M | $23.8M | $23.1M | $21.8M | $24.3M | $2.2M |
| Income before taxes | $704.0M | $604.8M | $457.7M | $345.3M | $240.6M | $237.2M | $234.3M | $186.7M | $129.7M | $144.5M |
| Income taxes | $91.9M | $162.2M | $119.4M | $79.4M | $41.4M | $40.8M | $48.4M | $27.4M | −$13.6M | $21.4M |
| Net income | $612.1M | $442.6M | $338.3M | $265.9M | $199.2M | $196.3M | $185.9M | $159.3M | $143.3M | $116.9M |
| EBITDA | $903.1M | $754.1M | $628.8M | $525.6M | $440.5M | $436.6M | $426.3M | $356.0M | $307.3M | $221.3M |
| EPS (diluted) | $11.72 | $11.12 | $8.79 | $7.62 | $6.52 | $5.73 | $5.31 | $4.68 | $4.09 | $3.61 |
| Gross margin | 66.4% | 66.7% | 67.7% | 68.7% | 67.5% | 65.9% | 66.2% | 65.6% | 64.8% | 66.7% |
| Operating margin | 21.9% | 20.0% | 18.3% | 15.4% | 13.7% | 14.7% | 15.2% | 13.7% | 11.3% | 13.2% |
| Net margin | 20.8% | 16.2% | 14.2% | 12.2% | 10.4% | 11.9% | 11.8% | 11.0% | 10.8% | 11.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $795.7M | $766.5M | $786.5M | $732.0M | $726.7M | $700.2M | $721.6M | $690.0M | $664.4M | $659.3M | $623.2M | $601.3M |
| Cost of revenue | $286.1M | $273.1M | $272.6M | $242.9M | $241.6M | $232.1M | $232.4M | $229.7M | $224.8M | $222.7M | $200.9M | $191.0M |
| Gross profit | $509.6M | $493.5M | $513.9M | $489.1M | $485.1M | $468.1M | $489.2M | $460.3M | $439.6M | $436.6M | $422.3M | $410.4M |
| Research & development | $104.6M | $97.2M | $91.1M | $90.5M | $89.8M | $89.1M | $94.8M | $91.5M | $86.5M | $87.8M | $81.1M | $84.8M |
| Sales, general & admin | $294.2M | $270.6M | $246.5M | $237.8M | $234.8M | $230.8M | $242.4M | $226.6M | $224.3M | $227.4M | $218.5M | $211.9M |
| Total operating expenses | $399.5M | $367.1M | $337.6M | $328.3M | $324.5M | $319.9M | $334.9M | $318.9M | $310.8M | $315.2M | $299.6M | $296.7M |
| Operating income | $110.1M | $126.4M | $176.2M | $160.8M | $160.6M | $148.2M | $154.3M | $141.4M | $128.8M | $121.4M | $122.7M | $113.6M |
| Interest income | — | $19.3M | — | $21.1M | — | $15.8M | $23.0M | $12.3M | — | $14.0M | $9.0M | $7.0M |
| Interest expense | — | — | — | — | — | — | $6.1M | — | — | — | $2.6M | $2.6M |
| Income before taxes | $109.5M | $145.7M | $182.7M | $181.9M | $175.4M | $164.0M | $171.2M | $153.7M | $144.5M | $135.4M | $120.0M | $120.7M |
| Income taxes | $24.8M | $99.0M | $32.1M | $37.1M | −$12.0M | $34.7M | $71.7M | $32.7M | $28.7M | $29.1M | $38.4M | $28.3M |
| Net income | $84.7M | $46.7M | $150.6M | $144.9M | $187.4M | $129.3M | $99.5M | $120.9M | $115.8M | $106.4M | $81.7M | $92.4M |
| EBITDA | $173.5M | $207.3M | $244.7M | $230.8M | $220.0M | $207.5M | $200.5M | $195.2M | $196.0M | $187.2M | $190.1M | $162.9M |
| EPS (diluted) | $1.95 | $2.64 | $3.24 | $3.18 | $3.01 | $2.29 | $3.02 | $2.88 | $2.64 | $2.58 | $2.36 | $2.27 |
| Gross margin | 64.0% | 64.4% | 65.3% | 66.8% | 66.8% | 66.9% | 67.8% | 66.7% | 66.2% | 66.2% | 67.8% | 68.2% |
| Operating margin | 13.8% | 16.5% | 22.4% | 22.0% | 22.1% | 21.2% | 21.4% | 20.5% | 19.4% | 18.4% | 19.7% | 18.9% |
| Net margin | 10.6% | 6.1% | 19.1% | 19.8% | 25.8% | 18.5% | 13.8% | 17.5% | 17.4% | 16.1% | 13.1% | 15.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in NICE's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
NICE financial results
In fiscal year 2025 (ended December 31, 2025), NICE reported revenue of $2.9 billion, up 7.7% from the year before. It had net income of $612.1 million (up 38.3%), a net profit margin of 20.8%. Diluted earnings per share came to $11.72. Over five years revenue grew at an average rate of 12.3% a year.
See the NICE stock overview for the latest quote and news, or the NICE chart for price history and technical indicators.
NICE income statement FAQ
What is NICE's annual revenue?
NICE reported total revenue of $2.9 billion for fiscal year 2025, which ended on December 31, 2025. That was up 7.7% from $2.7 billion the previous year.
Is NICE profitable?
Yes. NICE reported net income of $612.1 million in fiscal 2025, a net profit margin of 20.8%; its operating margin was 21.9%.
What is NICE's gross margin?
NICE's gross margin was 66.4% in fiscal 2025: for every $100 of revenue, NICE kept $66 after the direct cost of its products and services.
How much does NICE spend on research and development?
NICE spent $360.4 million on research and development in fiscal 2025, 12.2% of revenue.
How fast is NICE growing?
Revenue grew 12.3% a year on average over the last five fiscal years, from $1.6 billion to $2.9 billion.
What are NICE's earnings per share?
NICE earned $11.72 per diluted share in fiscal 2025, compared with $11.12 a year earlier.
When will NICE report its next earnings?
NICE is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 before the market opens.
When does NICE's fiscal year end?
NICE's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.